期刊文献+

甲状腺乳头状癌预后预测因素的研究进展 被引量:6

Advances in the study of prognostic factors for papillary thyroid carcinoma
原文传递
导出
摘要 目的探究预测甲状腺乳头状癌预后的因素。方法以"甲状腺乳头状癌预后""甲状腺乳头状癌超声检查""甲状腺乳头状癌与桥本甲状腺炎"和"甲状腺乳头状癌相关基因"为检索词进行文献检索,对现阶段发现的可以用于预测甲状腺乳头状癌预后的因素如患者的一般特征、原发灶的超声特征、血清学指标、相关基因的突变等做一综述。结果存在病灶直径大于1 cm、腺外浸润等超声特征和相关基因突变等因素,患者术后复发风险升高;合并桥本氏甲状腺炎的患者可能有更好的预后。结论目前有诸多因素在一定程度上都可以预测患者的复发风险,但基本都处于研究阶段,因此要提高生存率还得依靠更规范的术后随访管理。 Objective To explore the factors that predict the prognosis of papillary thyroid carcinoma.Method The literature searching terms include"prognosis of papillary thyroid carcinoma""ultrasound of papillary thyroid carcinoma""papillary thyroid carcinoma and Hashimoto's thyroiditis",and"genes related to papillary thyroid carcinoma".The factors used to predict the prognosis of papillary thyroid carcinoma such as the patient's clinical characteristics,ultrasound characteristics,serological indicators,genes mutations,etc.were reviewed.Results Ultrasound features such as lesion diameter greater than 1 cm,extra-glandular invasion,and related gene mutations may increase the risk of postoperative recurrence.Patients with Hashimoto's thyroiditis may have better prognosis.Conclusion There are many factors that can predict the risk of recurrence in patients to a certain extent,but most of them are just in the study,so it is necessary to enact more standardized follow-up management to improve the survival rate.
作者 周余 程若川 ZHOU Yu;CHENG Ruochuan(Department of Thyroid Surgery,the First Affiliated Hospital of Kunming Medical University,Kunming 650032,R.P.China)
出处 《中国普外基础与临床杂志》 CAS 2020年第8期1028-1032,共5页 Chinese Journal of Bases and Clinics In General Surgery
基金 云南省基础研究计划(昆医联合专项)[项目编号:2018FE001(–168)]。
关键词 甲状腺乳头状癌 预后 预测因素 综述 papillary thyroid carcinoma prognosis predictive factor review
  • 相关文献

参考文献7

二级参考文献65

  • 1唐韬,谭海东,黄林平.影响中青年分化型甲状腺癌患者预后因素的临床分析[J].中国实用医药,2007,2(10):1-4. 被引量:9
  • 2孙传政,陈福进,曾宗渊,宋明,李秋梨,杨安奎,张诠,魏茂文,伍国号.少年和青年分化型甲状腺癌的生存分析[J].中华耳鼻咽喉头颈外科杂志,2005,40(8):595-600. 被引量:27
  • 3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin, 2010,60(5 ) : 277-300. 被引量:1
  • 4Dal Maso L, Lise M, Zambon P, et al. Incidence of thyroid can- cer in Italy, 1991-2005: time trends and age-period-cohort ef- fects [ J ]. Ann Oncol, 2011,22 (4) : 957-963. 被引量:1
  • 5Jung KW, Won Y J, Kong H J, et al. Cancer statistics in Korea: in- cidence, mortality, survival and prevalence in 2010 [J]. Cancer Res Treat, 2013,45( 1 ) : 1-14. 被引量:1
  • 6WHO. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence in 2012 [R/OL]. [2015-06-17]. http://gloho- can. iarc. Fr/Pages/fact-. sheets-population, aspx. 被引量:1
  • 7Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets:Thyroid cancer[OL]. [2015-06-17]. http://seer. cancer.gov/statfacts/html/thyro.html. 被引量:1
  • 8Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015,65 ( 1 ) : 5-29. 被引量:1
  • 9De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EURO- CARE-5-a population-based study [ J ]. Lancet Oncol, 2014, 15( 1 ) :23-34. 被引量:1
  • 10Thomson CS, Forman D. Cancer survival in England and the in- fluence of early diagnosis: what can we learn from recent EU- ROCARE results? [J]. Br J Cancer, 2009, 101 (suppl2) : 102-109. 被引量:1

共引文献232

同被引文献75

引证文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部